AI assistant
Sending…
NEKTAR THERAPEUTICS — Director's Dealing 2010
Jan 6, 2010
32134_dirs_2010-01-06_1ffd66fe-01c2-4ba9-9071-707dffef213a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2010-01-06
Reporting Person: Doberstein Stephen K (Chief Scientific Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-01-06 | Stock Option | $9.53 | A | 540000 | Acquired | 2018-01-06 | Common Stock (540000) | Direct |
Footnotes
F1: 25% of the shares subject to the stock option vest on the first anniversary of the grant date (January 6, 2011) and the remainder of the shares subject to the stock option vest on a pro-rata monthly basis over the following three years.
More from NEKTAR THERAPEUTICS
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Capital/Financing Update
2026
May 8
Annual Report
2026
Apr 24
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 20